Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7577431

Concept As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
47,259,000,000 JPY
56,607,000,000 JPY
44,179,000,000 JPY
Ordinary profit (loss)
5,246,000,000 JPY
4,880,000,000 JPY
4,790,000,000 JPY
Net assets
54,080,000,000 JPY
48,892,000,000 JPY
48,412,000,000 JPY
Total assets
90,794,000,000 JPY
83,297,000,000 JPY
87,536,000,000 JPY
Basic earnings (loss) per share
148.19
64.97
151.22
143.76
242.10
Diluted earnings per share
Equity-to-asset ratio
0.596 xbrli:pure
0.587 xbrli:pure
0.553 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.